Abstract The combination of isotretinoin (13-cis-retinoic acid) with antiestrogens seems to be a promising strategy for cancer chemotherapy. The aim of the study was to evaluate the effects of isotretinoin alone or in combination with 4-hydroxytamoxifen (OHTAM) and with its prodrug tamoxifen (TAM), on the functions of rat liver mitochondria, i.e., mitochondrial permeability transition (MPT), bioenergetic functions and adenine nucleotide translocase (ANT). Isotretinoin (5 nmol/mg protein) induced the Ca 2+ -dependent MPT pore opening in mitochondria energized with succinate, which was prevented by OHTAM, cyclosporine A, TAM and ANT ligands. When mitochondria were energized with glutamate/malate and in the absence of added Ca 2+ isotretinoin decreased the state 3 respiration, the ATP levels, the active ANT content and increased the lag phase of the phosphorylation cycle, demonstrating that isotretinoin decreased the mitochondrial phosphorylation efficiency. These changes of isotretinoin in bioenergetic parameters were not significant in the presence of succinate. The effects of isotretinoin at 5 nmol/mg protein on the Ca 2+ -dependent MPT and phosphorylative efficacy may be related with interactions with the ANT. Above 10 nmol/mg protein isotretinoin strongly diminished the active ANT content, decreased the Δψ, inhibited the complex I and induced proton leak through the Fo fraction of complex V. The combination of OHTAM with isotretinoin only induced significant changes in the energy production systems at concentrations ≥5 nmol isotretinoin/mg protein. Therefore, our results suggest that isotretinoin-associated liver toxicity is possibly related with mitochondrial dysfunctions and that the combination with OHTAM may contribute to decrease its toxicity.
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Introduction
Isotretinoin (13-cis-retinoic acid), structurally related to vitamin A, is a first-generation retinoid often used for the treatment of many inflammatory skin disorders, and its use in the treatment of some cancers is currently under investigation (Njar et al. 2006; Norris et al. 2011; Pili et al. 2012 ). This compound achieves its remarkable efficacy by interfering with cell-cycle progression, cellular differentiation, cell survival and apoptosis in different cell types, including human breast cancer cells (Toma et al. 1997; Czeczuga-Semeniuk et al. 2001) , hepatoma (Arce et al. 2005 ) and melanoma cells (Lotan et al. 1980; Niu et al. 2005; Guruvayoorappan et al. 2008) . It has been described that the inhibition of cancer cell growth by isotretinoin is mediated through the nuclear retinoid receptors, i.e., retinoic acid receptor (RAR) and retinoid X receptor (RXR) (Chambon 1996) . However, it has been hypothesized that isotretinoin acts independently of the nuclear retinoid receptor pathway (Sabichi et al. 2003) , as suggested by the multiple side effects observed in patients treated with isotretinoin (Goodfield et al. 2010; Sardana & Garg 2011) . In addition, cell culture studies showed that isotretinoin induces several changes in mitochondria, such as a decrease in the expression of the antiapoptotic protein Bcl-2 (Guruvayoorappan et al. 2008; Vuletic et al. 2010 ) and the activation of caspase-3 (Arce et al. 2005; Guruvayoorappan et al. 2008) leading to cell death by apoptosis. It was also reported that isotretinoin (at concentrations from 4 to 33 μM or 16 to 132 nmol/mg protein) induces mitochondrial permeability transition (MPT) pore opening and the release of the cytochrome c (Rigobello et al. 1999 ). These results suggest that mitochondria may be involved in the toxicological effects induced by this retinoid.
The RARs are members of the thyroid-retinoid receptors family and have a basic structure that is also present in other nuclear receptors, such as the estrogen receptors (ER) (Chambon 1996) . It has been proposed that both RAR and ER take part of a "cross talk" pathway, as the inhibition of breast tumor cell growth by retinoids is more pronounced for ER-positive cells (Simeone & Tari 2004) . Furthermore, RAR activated appear to exert anti-estrogenic effects by directly or indirectly link the ER to estrogen response elements (EREs) (Demirpence et al. 1994) . Conversely, the N-terminal region of ERα modulates the transcriptional activity of RAR (Rousseau et al. 2003) . More recently, different works have demonstrated that retinoic acid receptor α (RARα) is probably an essential component of the ER (Ross-Innes et al. 2010) , and that these two nuclear receptors cooperate for effective transcriptional activity in breast cancer cells (Ross-Innes et al. 2010; Hua et al. 2009 ). These findings suggest the existence of an interplay between retinoid and estrogen signaling, and that the combination of isotretinoin with antiestrogenic compounds may be a promising therapy. In fact, it has been observed a synergistic action between retinoids and tamoxifen (TAM), a nonsteroidal antiestrogenic compound, on breast cancer cell death (Saez et al. 2003; Wang et al. 2007; Searovic et al. 2009 ). However, TAM is a prodrug with serious side effects (Wong & Ellis 2004 ) and patients present a large variation in both therapeutic efficacy and side effects due to CYP3A4 and CYP2D6 polymorphisms (Damodaran et al. 2012) . 4-hydroxytamoxifen (OHTAM), a major active metabolite, responsible for the anticancer activity of TAM, is a promising compound since this metabolite has a higher affinity for ER, and it is 30-to 200-times more potent than TAM (Lim et al. 2005; Kiyotani et al. 2012 ). In addition, it is pharmacologically well tolerated (Sauvez et al. 1999 ) and has less side effects (Cardoso et al. 2002a; Cruz Silva et al. 2001) . However, although the combined therapy of antiestrogens with isotretinoin seems to be a good strategy for cancer treatment, the effects of this retinoid in combination with OHTAM or TAM on mitochondria have not been studied.
Considering that mitochondrial damage is a triggering event for deregulation of cell homeostasis (Lemasters et al. 2009; Starkov 2010; Wallace 2008; Fulda et al. 2010) , mitochondria fractions are a useful in vitro model to investigate drug toxicity/safety (Labbe et al. 2008) . Therefore, the purpose of this study was to evaluate the combined action of OHTAM or TAM with isotretinoin on rat liver mitochondria and the ability of OHTAM and TAM to prevent isotretinoininduced MPT and bioenergetic dysfunction. This study may contribute to clarify the mechanisms of apoptosis and hepatotoxicity promoted by isotretinoin that must always be considered during drug development and even for drugs under therapeutic use (Labbe et al. 2008 ).
Materials and methods

Isolation of rat liver mitochondria
Mitochondria were isolated from the liver of Wistar rats by differential centrifugation as described elsewhere (Gazotti et al. 1979) , with slight modifications (Moreira et al. 2006 ). Rats were killed by cervical dislocation, and their liver was immediately excised and cooled at 4°C in the homogenization medium containing 250 mM sucrose, 10 mM 4-(2-hydroxymethyl)-1-piperazineethanesulfonic acid (HEPES) (pH 7.4), 1 mM NNN′N-tetraacetic acid (EGTA) and 0.1% (w/v) bovine serum albumin (BSA) fat-free. The homogenate was centrifuged at 800×g for 10 min and mitochondria were recovered from the supernatant by centrifugation at 10 000×g for 10 min. The EGTA was omitted from the final washing medium and the final mitochondrial pellet was washed twice. Mitochondrial protein concentration was determined by the biuret method using BSA as the protein standard (Gornall et al. 1949 ).
Mitochondrial membrane potential (Δ=)
The mitochondrial membrane potential (Δ=) was monitored by evaluating the transmembrane distribution of tetraphenylphosphonium (TPP + ) with an ion-selective electrode, prepared according to Kamo et al. (1979) , and using a Ag/AgCl 2 electrode as reference (model MI 402; Microelectrodes, Inc., Bedford, NH). The Δ= was estimated from the following equation: Δ==59×log (v/V) -59×log (10 ΔE/59 −1), where v, V, and ΔE stand for inner mitochondrial volume, incubation medium volume, and deflection of the electrode potential from the baseline, respectively. A matrix volume of 1.1 μl/mg of protein was assumed.
To monitor Δ= associated to mitochondrial respiration, liver mitochondria (1 mg) were incubated at 30°C for 3 min, in 2 ml of standard respiratory reaction medium (130 mM sucrose, 50 mM KCl, 5 mM MgCl 2 , 0.1 mM EGTA, 5 mM KH 2 PO4, 5 mM Hepes, pH 7.4) supplemented with 4 μM TPP + prior to the addition of 5 mM glutamate/2.5 mM malate or 5 mM succinate to energize mitochondria. Isotretinoin was added to the medium after protein addition and incubated for 2 min before starting the reactions. After steady-state distribution of TPP + , ADP (150 nmol/mg protein) was added to initiate state 3 respiration. Δ= was estimated from the decrease of TPP + concentration in the reaction medium. The Δ= associated to MPT induction was determined with mitochondria (0.5 mg/ml) incubated in 2 ml of MPT reaction medium (200 mM sucrose, 10 mM Tris-Mops, 1 mM KH 2 PO 4 and 10 μM EGTA, pH 7.4) supplemented with 4 μM TPP + and 2 μM rotenone in the absence and in the presence of 1 μM cyclosporine A (CyA), thiol protecting and antioxidant agents [1 mM dithiothreitol (DTT), 50 μM (Custodio et al. 2002) . CyA, TAM and OHTAM were also added during the Δ= depolarization as indicated in the figure legends.
Measurements of Ca 2+ fluxes
Mitochondrial Ca 2+ fluxes were evaluated by monitoring the changes in Ca 2+ concentration in the MPT reaction medium by using a Ca 2+ -sensitive electrode (Madeira 1975; Cardoso et al. 2004 ). The reactions were carried out with mitochondria (1 mg) in 2 ml of the MPT reaction medium, at 30°C, in an open vessel, with a constant stirring. The experiments were started by the addition of 5 mM succinate 1 min after Ca 
Mitochondrial oxygen consumption
Mitochondria (1 mg) were incubated in 1 ml of standard respiratory reaction medium (130 mM sucrose, 50 mM KCl, 5 mM MgCl 2 , 0.1 mM EGTA, 5 mM KH 2 PO4, 5 mM Hepes, pH 7.4) in the absence or presence of isotretinoin, TAM and OHTAM. The reactions were performed at 30°C in a closed chamber fitted with a Clark-type oxygen electrode (YSI model 5331, Yellow Spring Inst.) and the drugs were added to the respiratory medium and incubated with mitochondria for 2 min before starting the reactions. Respiration state 3 was initiated by the addition of ADP (200 nmol/mg protein), after energization with 5 mM glutamate/2.5 mM malate or succinate. When succinate was used as the respiratory substrate, the medium was supplemented with 2 μM rotenone. After phosphorylation of all the ADP added, the oxygen consumption rate decreased and state 4 respiration was resumed. The state 4 oligomycin (state 4 olig) was induced by the addition of oligomycin (1 μg/mg protein) plus ADP to evaluate the proton leak through the Fo fraction of complex V of the respiratory chain. p-trifluormethoxyphenylhydrazone (FCCP)-uncoupled respiration was promoted by the addition of FCCP (1 μM). Respiration rates were calculated assuming an oxygen concentration of 240 nmol O 2 /ml at 30°C. The respiratory control ratio (RCR) was calculated by the ratio between state 3 and state 4 respirations and ADP/O by the ratio between the amount of ADP added and the O 2 consumed during state 3 respiration, as reported by Chance and Williams (Chance & Williams 1956 ).
HPLC determination of adenylates
Adenine nucleotides (ATP and ADP) were extracted using an acidic extraction procedure and were separated by reverse-phase HPLC (Stocchi et al. 1985) . The acidic extraction was performed, as follows: mitochondria (1 mg) were incubated in 1 ml standard respiratory reaction medium (130 mM sucrose, 50 mM KCl, 5 mM MgCl 2 , 0.1 mM EGTA, 5 mM KH 2 PO4, 5 mM Hepes, pH 7.4) in the absence (control) or in the presence of isotretinoin. After the incubation period (2 min), 5 mM glutamate/2.5 mM malate was added to induce the state 2 respiration and, 2 min later, the state 3 respiration was induced by the addition of 150 nmol ADP. After 1 min reaction, 250 μL of the suspension were added to 250 μL ice-cooled HClO 4 0.6 M (EDTA-Na 25 mM). This mixture was centrifuged at 10 000 rpm for 2 min at 4°C and the supernatants were neutralised with KOH 3 M and Tris 1.5 M. The samples were centrifuged at 10 000 rpm for 2 min and stored at −80°C until chromatographic analysis. All the extraction procedure was carried out at 0-4°C to minimize degradation of nucleotides. The chromatographic apparatus used was a Beckman System Gold, consisting of a 126 Binary Pump Model and a 166 Variable UV detector controlled by computer. The protocol used consisted of an isocratic elution with 100 mM KH 2 PO 4 , pH=6.5, and containing 1.2% methanol. The flow rate was 1 ml/min and the nucleotides detected at 254 nm (Cardoso et al. 2003; Monteiro et al. 2005 ).
Determination of active ANT content Mitochondria (0.5 mg) were incubated in 1 ml of standard reaction medium (200 mM sucrose, 5 mM KH 2 PO4, 20 mM Tris-HCl, pH 7.4). The reaction was performed at 30°C in a closed chamber fitted with a Clark-type oxygen electrode (YSI model 5331, Yellow Spring Inst.). The active ANT content (ANT activity) was determined by titrating the rate of state 3 respiration with increasing concentrations of carboxyatractyloside (CAT) (Vignais 1976) . Mitochondria were incubated in the absence or presence of isotretinoin and 2 min later CAT was added to mitochondria. After the incubation period (1 min), the reactions were started by the addition of 5 mM glutamate/2.5 mM malate and state 3 respiration was initiated by adding 0.1 mM ADP. Plots of O 2 consumption versus CAT concentration are biphasic, with an increasing inhibitory effect followed by a steady-state effect which corresponds to the complete inhibition of state 3 respiration. The amount of CAT corresponding to complete inhibition of state 3 respiration was used to estimate ANT content assuming a 1:1 binding stoichiometry (Rousseau et al. 2003 ; Zhou et al. 
Statistical analysis
The results are expressed as the mean ± SE of four independent experiments and data were analysed using one-way ANOVA analysis of variance with Tukey multiple comparison test. A p-value<0.05 was considered statistically significant.
Results
Effect of antiestrogenic compounds on MPT pore opening induced by isotretinoin
The Fig. 1a presents the effects of isotretinoin alone or in combination with TAM or OHTAM on Ca 2+ -dependent MPT evaluated by the dissipation of Δ=. In the absence of isotretinoin, the addition of Ca 2+ (120 nmol/mg protein) to succinateenergized mitochondria caused a transient depolarization of Δ= followed by fast repolarization after Ca 2+ accumulation, showing capacity to sustain Δ= (Fig. 1a -Ca 2+ alone). In contrast, the addition of 200 nmol Ca 2+ /mg protein caused an irreversible depolarization of Δ= after Ca 2+ addition (results not shown). The pre-incubation of mitochondria with isotretinoin (5 nmol/mg protein or 2.5 μM) caused an irreversible depolarization of Δ= after addition of 120 nmol Ca 2+ /mg protein ( Fig. 1a-isotretinoin) . The Δ= dissipation induced by isotretinoin was completely inhibited by CyA (Fig. 1a-CyA) , a specific MPT inhibitor (Broekemeier et al. 1989 ). The preincubation of mitochondria with 5 μM TAM or 5 μM OHTAM (10 nmol/mg protein) afforded complete protection against the irreversible depolarization induced by isotretinoin (Fig. 1a -TAM and OHTAM). Moreover, the addition of TAM or OHTAM during the depolarization of Δ= promoted by isotretinoin induced repolarization of Δ= in a similar way to CyA (Fig. 1a) , indicating that these compounds have the ability to prevent and revert the MPT induced by isotretinoin.
TAM and OHTAM are potent inhibitors of MPT pore opening probably due to its antioxidants properties (Custodio et al. 1998; Cardoso et al. 2002b) . Therefore, to clarify the biochemical mechanisms by which MPT pore opening is potentiated by isotretinoin, we evaluated the effects of thiol protecting and antioxidants agents that prevent the MPT pore opening induced by oxidative stress mechanisms. As shown in Fig. 1b , the pre-incubation of mitochondria with thiol protecting and antioxidants agents, namely DTT, NEM, Cys, NAC, Asc and GSH did not prevent the Δ= depolarization induced by isotretinoin, in contrast to that observed with TAM and OHTAM (Fig. 1a) . However, ANT ligands, ADP or ATP added to the mitochondria prior to the pre-incubation with isotretinoin, inhibited the irreversible mitochondrial depolarization (Fig. 1b-ADP (Fig. 2-isotretinoin) . As observed with the TPP + -sensitive electrode (Fig. 1) , CyA prevented the isotretinoin effects on Ca 2+ release (Fig. 2-CyA) . Again, the addition of TAM or OHTAM before or after the MPT induction by isotretinoin afforded a complete protection against the release of the accumulated Ca 2+ (Fig. 2-TAM, OHTAM) . However, and similarly to what was observed with the TPP + -sensitive electrode (Fig. 1b) , the addition of thiol protecting and antioxidant agents did not prevent the release of the accumulated Ca 2+ by mitochondria. The addition of ADP, an ANT ligand, before isotretinoin and Ca 2+ inhibited the release of Ca 2+ ( Fig. 2-ADP) .
Effect of isotretinoin on rat liver mitochondrial bioenergetics
The effects of isotretinoin were evaluated on oxygen consumption and Δ= of rat liver mitochondria (Figs. 3, 4 , 5 and 6). Isotretinoin pre-incubated with mitochondria energized with glutamate/malate significantly decreased the state 3 respiration in a concentration dependent way (Fig. 3a) . At 5 and 10 nmol/mg protein (5-10 μM) isotretinoin did not induce statistically significant alterations in the state 4 respiration, but 20 nmol isotretinoin/mg protein significantly stimulated the state 4 respiration (Fig. 3a) . The addition of ADP and oligomycin (state 4 oligomycin) to mitochondria pre-incubated with 5 and 10 nmol isotretinoin/mg protein induced a decrease in the state 4 oligomycin, though without statistical significance. At higher concentrations (≥ 20 nmol/mg protein), the addition of oligomycin decreased the oxygen consumption stimulated by isotretinoin (Fig. 3a) . FCCP-uncoupled respiration was significantly decreased above 10 nmol isotretinoin/mg protein (Fig. 3a) . The effects of isotretinoin on the respiration rates, supported by succinate (Fig. 3b) , were slightly different from those observed with glutamate/malate (Fig. 3a) . As presented in Fig. 3b , the state 4 respiration was significantly stimulated at concentrations above 10 nmol isotretinoin/mg protein (Fig. 3a) . State 3 was not significantly affected by 5 nmol isotretinoin/mg protein and at concentrations above 10 nmol isotretinoin/mg protein the effects were less pronounced than in glutamate/malate supported respiration (Fig. 3b) . Concerning FCCP-uncoupled respiration, we found that isotretinoin did not significantly affect this parameter at concentrations bellow 20 nmol isotretinoin/mg protein in mitochondria energized with succinate (Fig. 3b) . Moreover, at concentrations of 20 nmol isotretinoin/mg protein the FCCP-uncoupled respiration was less affected (Fig. 3b) , as compared with energization with glutamate/malate (Fig. 3a) .
In mitochondria energized with glutamate/malate (Fig. 4a ) the RCR and ADP/O indices were also slightly different from those observed with succinate (Fig. 4b ). The addition of 5 nmol isotretinoin/mg protein to mitochondria energized with glutamate/malate induced a significant decrease in RCR (Fig. 4) . In the presence of higher concentrations of isotretinoin Results are presented as the mean ± SE of four experiments obtained from different mitochondrial preparations (when the error bars are not visible, SE is encompassed by the size of the symbols). ***p<0.001, **p<0.01 and *p<0.05 when compared with the respective control (in the absence of isotretinoin) (>10 nmol/mg protein) this decrease was much more pronounced, as compared to control conditions (Fig. 4a) , mainly due to the decrease in state 3 respiration. At concentrations of isotretinoin above 20 nmol/mg protein, the RCR ratio approaches 1.0 (Fig. 4a) , suggesting that the phosphorylation of ADP did not occur due to an uncoupling effect on mitochondrial respiration. The ADP/O index was also decreased and for 20 nmol isotretinoin/mg protein we were not able to determine the ADP/O ratio, because mitochondria were uncoupled, as shown by the RCR index (Fig. 4a) . In mitochondria energized with succinate (Fig. 4b) , the RCR was not significantly affected by 5 nmol isotretinoin/mg protein and it was less decreased at concentrations of 10 nmol isotretinoin/mg protein (Fig. 4b) . However, this decrease is mainly a consequence of the stimulation of state 4 (Fig. 3b) , since the state 3 respiration was less diminished when compared with mitochondria energized with glutamate/malate. Additionally, the RCR approaches a value of 2.0 for concentrations above 20 nmol isotretinoin/mg protein (Fig. 4b) , meaning that mitochondria are not completed uncoupled, as observed with glutamate/malate (Fig. 4a) . Relatively to the ADP/O, we found that this index was also decreased at concentrations above 10 nmol isotretinoin/mg protein (Fig. 4b) , but the phosphorylative capacity of hepatic mitochondria in the presence of succinate was less affected than in mitochondria energized with glutamate/malate (Fig. 4a) .
The depressive effect of isotretinoin on the phosphorylation capacity of mitochondria was further evaluated by following the Δ= fluctuations associated with the phosphorylation cycle induced by ADP (Figs. 5 and 6 ). After the addition of glutamate/malate (Fig. 5) , in the absence of isotretinoin, mitochondria developed a Δ= of about 219.9±1.3 mV (negative inside). The addition of isotretinoin at concentrations of 5 and 10 nmol/mg protein did not significantly affect the mitochondrial Δ=. However, at 20 nmol isotretinoin/mg protein, we found a significant decrease in the Δ= (Fig. 5) . The addition of ADP in the absence of isotretinoin dropped the Δ= in 25.1±1.6 mV (ADP depolarization). The preincubation with isotretinoin at concentrations above 10 nmol/mg protein decreased the ADP depolarization (Fig. 5) . The time required for the phosphorylation of ADP (lag phase) in the absence of isotretinoin was 63.4±1.7 s, while the addition of 5 and 10 nmol isotretinoin/mg protein induced a significant increase (Fig. 5) . At 20 nmol isotretinoin/mg protein the lag phase was not measured since the phosphorylation of ADP did not occur in agreement with the RCR index (Fig. 4a) . When ADP phosphorylation occurred, the repolarization and the transmembrane potential returned to the initial value (−219.6±1.0 mV). In the presence of 5 and 10 nmol/mg protein, isotretinoin did not change the potential repolarization. At concentrations above 20 nmol isotretinoin/mg protein the repolarization did not occur and mitochondria had no capacity to sustain the Δ= (Fig. 5) .
In mitochondria energized with succinate (Fig. 6) , the results were slightly different, when compared with those observed with glutamate/malate (Fig. 5) . In fact, the lag phase of phosphorylation cycle was only significantly affected at concentrations above 10 nmol isotretinoin/mg protein in mitochondria energized with succinate (Fig. 6) , while 5 nmol isotretinoin/mg protein decreased the lag phase in mitochondria energized with glutamate/malate (Fig. 5) . On the contrary, in mitochondria energized with glutamate/malate, the Δ= developed after the addition of 20 nmol isotretinoin/mg protein was not affected (Fig. 6) . Furthermore, at 30 nmol isotretinoin/mg protein, mitochondria energized with succinate had the capacity to maintain the Δ= after the addition of ADP (data not shown), in contrast to that observed in mitochondria pre-incubated with 20 nmol isotretinoin/mg protein and energized with glutamate/malate.
Effect of isotretinoin on the active ANT content
The active ANT content (ANT activity) was also determined to clarify the MPT pore opening and the changes in the mitochondrial phosphorylation induced by isotretinoin (Fig. 7) . The mitochondrial content of active ANT was determined by the amount of CAT required to reduce state 3 respiration to the Fig. 6 Effect of isotretinoin on succinate-dependent transmembrane potential (Δ=) of rat liver mitochondria. The traces represent typical records from experiments performed in the conditions described in "Material and Methods". The arrows indicate the additions of 5 mM succinate (Suc), 150 nmol ADP/mg protein (ADP), and the numbers on the right of the traces are the concentrations of isotretinoin. Data in the table below, present the mean ± SE of the transmembrane potential at the different concentrations of isotretinoin. ***p<0.001 and *p<0.05 vs control (in the absence of isotretinoin) Fig. 7 Effect of isotretinoin on mitochondrial active adenine nucleotide translocase (ANT) content. The experiments were performed out as described in "Material and Methods" and data are expressed as pmol carboxyatractyloside (CAT) per mg of mitochondrial protein. The values are present as the mean ± SE of four different experiments, using different mitochondrial preparations. ***p<0.001 and **p<0.01 vs control (in the absence of isotretinoin) state 4 respiration rate, when CAT saturates the translocase sites (Vignais 1976 ). In the absence of isotretinoin, the ANT was only inhibited by the addition of 468 pmol CAT/mg protein. However, in the presence of 5 and 10 nmol isotretinoin/mg the active ANT content was decreased to about 222 and 97 pmol CAT/mg protein, respectively (Fig. 7) , which corresponds to approximately 47% and 21% of the control. At 20 nmol/mg protein, isotretinoin inhibited almost completely the active ANT content, suggesting that isotretinoin interferes with the ANT in a concentration dependent way.
Effect of isotretinoin combined with antiestrogens on mitochondrial phosphorylation efficiency
Besides the inhibition of isotretinoin-induced MPT (Figs. 1  and 2 ), the effects of isotretinoin in combination with OHTAM Fig. 8 Effect of isotretinoin alone (5 nmol/mg protein) or in combination with antiestrogenic compounds (10 nmol/mg protein) on glutamate/malate-supported respiration. The rates of O 2 consumption (a) in state 3, (b) state 4 and state 4 oligomycin (state 4 olig), (c) FCCP-uncoupled respiration, and the respiration indices, (d) respiratory control ratio (RCR) and (e) ADP/O of rat liver mitochondria, are shown. Results are presented as the mean ± SE of four experiments using from different mitochondrial preparations. ***p<0.001, **p<0.01 and *p<0.05 when compared with the control (in the absence of isotretinoin) conditions. +++ p<0.001, ++ p< 0.01 when compared with isotretinoin alone or TAM were also evaluated on respiratory chain (Fig. 8) and on the energetic levels (Table 1) of mitochondria.
The combination of 5 nmol isotretinoin/mg protein (5 μM) with OHTAM or TAM (10 nmol/mg protein or 10 μM) induced a significant decrease in state 3 respiration (Fig. 8a) . However, this decrease was not statistically significant when compared with isotretinoin alone (5 nmol/mg protein) that was able to induce a decrease in state 3. The state 4 respiration was not significantly stimulated when isotretinoin was combined with OHTAM (Fig. 8b) . On the contrary, isotretinoin in combination with TAM induced a significant increase in state 4 respiration, as compared to the control and isotretinoin alone. The fact that the addition of oligomycin did not decrease the oxygen consumption stimulated by TAM combined with isotretinoin (Fig. 8b) suggests that the state 4 stimulation induced by this association is not due to proton leak through Fo fraction of complex V of the respiratory chain. By monitoring the changes in the FCCP-uncoupled respiration (Fig. 8c) , we found that the studied associations did not inhibit the respiratory chain activity. In agreement with the results obtained for state 3 and state 4 respiration, the combination of isotretinoin with OHTAM did not decrease significantly the RCR ratio (Fig. 8d) . However, the combination of isotretinoin with TAM induced a significant decrease in the RCR value (Fig. 8d) , as a consequence of the stimulation of state 4 respiration (Fig. 8b) . The ADP/O ratio was not changed by the combination of isotretinoin with OHTAM or TAM (Fig. 8e) .
The effects of isotretinoin alone or in combination with either TAM or OHTAM on the mitochondrial energetic levels were also determined by evaluating the ATP and ADP contents by HPLC (Table 1 ). The addition of 5 nmol isotretinoin/mg protein (5 μM) induced a significant decrease in the ATP levels, while the ADP levels increased. These effects were more pronounced in the presence of higher concentrations of isotretinoin (≥10 nmol/mg protein) ( Table 1 ), suggesting that phosphorylation is compromised, according to the RCR index (Fig. 54a) and to the phosphorylation cycle (Figs. 3a and 5) . Interestingly, the co-incubation of mitochondria with isotretinoin (5 nmol/mg protein) and TAM or OHTAM (10 nmol/mg protein) did not induce significant changes in the ATP and ADP levels (Table 1) , and the values were similar to those observed in the presence of both antiestrogens individually (data not shown), as previously reported (Cardoso et al. 2003) .
Discussion
This study demonstrates that isotretinoin is an effective inducer of the Ca 2+ -dependent MPT pore opening (Figs. 1 and 2 ), in agreement with Rigobello et al. (1999) . In our experimental conditions, isotretinoin promoted MPT pore opening at 5 nmol/mg protein (2.5 μM), which is lower than the concentration used by Rigobello et al. (1999) (4 to 33 μM or 16 to 132 nmol/mg protein). Isotretinoin at 5 nmol/mg protein did not affect the respiratory chain (Figs. 3 and 4) , and did not alter the Δ= developed by mitochondria (Figs. 5 and 6) . Moreover, the depolarization of Δ= and the release of Ca 2+ associated to MPT induction by 5 nmol isotretinoin/mg protein were reverted by the addition of CyA after the pore opening ( Figs. 1 and 2 ), suggesting that isotretinoin is directly affecting the conformational structure of the constituents of the mega protein complex comprising the MPT pore. Isotretinoin changed significantly the mitochondrial respiration and the oxidative phosphorylation only at concentrations higher than 5 nmol/mg protein (Figs. 3, 4 , 5 and 6) ( Table 1 ). The modulation of the MPT has been associated with the orientation of the ADP/ATP translocase across the inner membrane. Our data strengthens this hypothesis, as we found that isotretinoin at concentrations higher than 5 μM strongly alters the active ANT content (ANT activity) (Fig. 7) .
Our study demonstrated that the isotretinoin-induced Ca 2+ -dependent Δ= depolarization (Fig. 1) and Ca 2+ release (Fig. 2 ), due to MPT promotion, were prevented and reverted by TAM and OHTAM, suggesting that both antiestrogens are inhibitors of the MPT pore opening induced by isotretinoin. It has been documented that the MPT induction may occur following an oxidative stress event (Halestrap et al. 1997) . In opposition to TAM and OHTAM, known as intramembranous antioxidants (Custodio et al. 1994) , the addition of thiol protecting and antioxidant agents (DTT, NEM, Cys, NAC, Asc and GSH) did not prevent the MPT pore opening induced by isotretinoin (Figs. 1b and 2) . Thus, the use of these compounds that are effective inhibitors of permeability transition, demonstrates that isotretinoin-induced MPT cannot be related to oxidative alterations of the mitochondrial proteins of the MPT pore.
ANT ligands, such as ATP and ADP, prevented the MPT pore opening induced by isotretinoin (Figs. 1b and 2 ). Both adenine nucleotides inhibited pore opening by binding to both highand low-affinity sites of the ANT, preventing calcium from inducing the cyclophilin-D-mediated conformational change (Halestrap & Pasdois 2009) . Isotretinoin can induce the MPT through an interaction with the mitochondrial cyclophilin-D and the adenine nucleotide translocator, which is in accordance with the effects obtained by titration of mitochondria with carboxyatractyloside ( Fig. 7) . Noteworthy, photoaffinity labeling studies have demonstrated that tretinoin (all-trans-retinoic acid) directly binds to the ANT (Notario et al. 2003) . We may, therefore, propose that as occurs with carboxyatractyloside, isotretinoin can promote pore opening by stabilizing ANT in the cytosolic side of the inner membrane. Our hypothesis seems to be in agreement with the inhibition of the MPT by TAM and OHTAM. As the antiestrogens do not significantly affect the active ANT content at the concentrations used to inhibit isotretinoin-induced MPT (Cardoso et al. 2003) , it is plausible that the antiestrogens, which strongly partition in the core of biomembranes (Custodio et al. 1991) , prevent the MPT induced by isotretinoin through the decrease of membrane fluidity (Custodio et al. 1993; Kazanci & Severcan 2007) . This effect would indirectly compromise the activity of membrane proteins, such as the ANT. These multiple mechanisms of antiestrogens may prevent the conformational changes promoted by isotretinoin, which are involved in the MPT induction. Isotretinoin-induced changes observed in mitochondrial functions and in different cancer cell lines (Arce et al. 2005; Guruvayoorappan et al. 2008; Vuletic et al. 2010) were also observed with other drugs (Kass 2006 ) and may explain some side effects described in patients treated with isotretinoin (Goodfield et al. 2010; Sardana & Garg 2011) . Thus, the association of TAM or OHTAM with isotretinoin therapy may be crucial to reduce or avoid the adverse effects observed in monotherapy with isotretinoin. Moreover, the interaction of isotretinoin with the ANT, a regulatory element of the MPT pore (Pebay-Peyroula & Brandolin 2004; Zorov et al. 2009 ), suggests a possible mechanism for MPT pore induction and may also explain the decrease in state 3 respiration (Fig. 3a) since, as reported above, isotretinoin at 5 nmol/mg protein did not induce any other change responsible for this effect (Figs. 3, 4 , 5 and 6).
Our study also showed that isotretinoin induced more significant changes in different mitochondrial functions at concentration above 10 nmol/mg protein. In fact, isotretinoin depressed the phosphorylation capacity of hepatic mitochondria, as shown by the decrease in state 3 respiration (Fig. 3a) , RCR, ADP/O indices (Fig. 4a) , ATP levels (Table 1) and by the increase in the lag phase of ADP phosphorylation cycle (Fig. 5) . Nevertheless, isotretinoin at this concentration slightly affected the respiratory chain, as suggested by its effect on FCCP-uncoupled respiration (Fig. 3a) , and in the membrane potential developed by mitochondria (Fig. 5) . However, the results demonstrated that isotretinoin significantly decreased the ANT content (Fig. 7) , indicating that the interaction with this component of the phosphorylation system, may be the main factor involved in the decrease of mitochondrial phosphorylative efficiency induced by isotretinoin. At higher concentrations (≥ 10 nmol/mg protein) isotretinoin significantly potentiated the mitochondrial dysfunctions described above and uncoupled the mitochondrial respiration as inferred from the decrease in the respiratory control ratio (Fig. 3a) , ADP/O index ( Fig. 4a) and from the effects on the ADP phosphorylation cycle (Fig. 5 ). This effect is probably due to the strong changes induced in the active ANT content (Fig. 7) and to its ability to affect the conformational structure of complex V proteins, namely the fraction Fo of ATP synthase, inducing leak of protons as evidenced by the effects on state 4 oligomycin ( Fig. 3a) and by the decrease in Δ= (Fig 5) . The inhibitory effect on the respiratory chain complex I is inferred from the significant decrease in the FCCP-uncoupled respiration (Fig. 3a) and the Δ= developed by mitochondria energized with glutamate/malate (Fig. 5) , as compared with the slight changes induced in mitochondria energized with succinate ( Figs. 3b  and 6 ). This inhibitory effect on respiratory complex I also contributes to the impairment of mitochondria promoted by high concentrations of isotretinoin. It is possible that these mitochondrial dysfunctions may underlie or contribute to the numerous side effects observed in patients treated with high isotretinoin concentrations (Goodfield et al. 2010; Sardana & Garg 2011) . Thus, the combination of isotretinoin with other compounds would be an important therapeutic approach, by promoting an additive/synergistic therapeutic action and an important improvement in patient's quality of life, as the use of lower concentrations of each compound would lead to a reduction in the adverse side effects.
When we combined low concentrations of isotretinoin (5 nmol/mg protein) with TAM or OHTAM (10 nmol/mg protein), besides the protective effect observed in the MPT pore opening, no significant changes were observed in the oxidative phosphorylation system and in the respiratory chain (Fig. 8) , as compared with isotretinoin alone. An exception was observed when isotretinoin was combined with TAM, occurring a stimulation of the state 4 that is possibly due to the permeabilization of the inner mitochondrial membrane to protons, induced by TAM, as previously described by Cardoso et al. (2001) . Moreover, TAM and OHTAM, which at the concentrations tested did not change the mitochondria phosphorylation efficiency (Cardoso et al. 2003) , promoted a reduction in the ATP depletion induced by isotretinoin (Table 1) . The prevention of isotretinoininduced MPT by both antiestrogens (Figs. 1 and 2) , may rely on the fact that TAM and OHTAM lock the ANT on the mitochondrial membrane, diminishing the interaction of isotretinoin with the adenine nucleotide carrier or competing for the binding sites of isotretinoin in the ANT.
Our data show that isotretinoin induces different dysfunctional changes in mitochondria. These mitochondrial dysfunctions include an increase in the sensitivity of mitochondria to Ca 2+ -induced MPT, which is prevented by TAM and OHTAM, and bioenergetic damaging effects. Mitochondrial dysfunction is a triggering event for cell toxicity and death, due to their crucial role in cell homeostasis. Our studies in mitochondria suggest that isotretinoin-associated liver toxicity and apoptosis is possibly related with mitochondrial dysfunctions due to interactions with the ANT. The abnormalities in liver functions and systemic side effects observed in patients treated with this retinoid (Erturan et al. 2012 ) may be related with the mitochondrial damage described since the concentrations of isotretinoin used in our experiments (5-10 nmol/mg protein or 5-10 μM) correspond to those that are usually achieved in blood with therapeutic doses of 160 mg/m2/day (7.2±5.3 μM) (Erturan et al. 2012; Veal et al. 2007) , although different studies indicated a >10-fold inter-patient variation in plasma concentrations. Plasma concentrations above 10 μM were correlated with an increased incidence of hepatic toxicity, hyperkaliemia and hipercalcemia (Erturan et al. 2012) . Therefore, we propose that the use of isotretinoin combined with OHTAM can reduce the side effects on proteins responsible for Ca 2+ homeostasis and energy production in the cell. Further in vivo studies are required to clarify the toxicity and safety of the combination of isotretinoin with antiestrogens in humans, in order to establish the therapeutic efficacy of this therapy.
